Hanover Insurance Group (THG) reported an insider Form 4 for its President and CEO, who is also a Director, detailing a charitable gift of 590 shares of common stock on 11/05/2025 at $0 (transaction code G).
Following the transaction, the reporting person directly beneficially owns 124,096.639 shares. A note states this total does not include 14,454 shares held by the reporting person’s spouse.
Hanover Insurance Group (THG) Executive Vice President reported a charitable gift of 175 shares on 11/04/2025 on Form 4. The transaction was coded G (gift) at a price of $0. After this transaction, the reporting person directly owned 9,890.273 shares of common stock.
The Hanover Insurance Group (THG) reported stronger Q3 2025 results. Total revenues were $1,665.0 million, up from $1,565.3 million a year ago, driven by premiums of $1,550.7 million and higher net investment income of $117.0 million. Income from continuing operations rose to $178.6 million versus $102.1 million, and diluted EPS from continuing operations increased to $4.90 from $2.80. Net income was $178.7 million.
Underwriting costs remained controlled as losses and loss adjustment expenses were $927.1 million versus $954.0 million. Other comprehensive income improved with available‑for‑sale securities appreciation of $88.4 million. On the balance sheet, cash and cash equivalents were $915.7 million versus $435.5 million at December 31, 2024, while total investments reached $10,367.4 million. Debt rose with short‑term debt at $436.8 million and long‑term debt at $843.0 million. For the nine months, operating cash flow was $799.9 million; dividends paid were $98.2 million and share repurchases were $74.9 million. Shares outstanding were 35,583,964 as of October 28, 2025.
The Hanover Insurance Group (THG) furnished quarterly results materials under Item 2.02 of Form 8-K. On October 29, 2025, the company announced a press release for the quarter ended September 30, 2025, and made available an unaudited Financial Supplement on its website. The press release and supplement are furnished as Exhibit 99.1 and Exhibit 99.2, respectively.
This 8-K provides access to the company’s Q3 2025 results materials and supporting data; the information is furnished rather than filed.
The New York Stock Exchange filed Form 25 to remove Hanover Insurance Group’s 7 5/8% Senior Debentures due October 15, 2025 from listing and/or registration under Section 12(b) of the Exchange Act. The Exchange certified it complied with its rules to strike the class, and the issuer complied with the Exchange’s rules and SEC requirements governing voluntary withdrawal.
John C. Roche, President and CEO and Director of The Hanover Insurance Group, Inc. (THG), reported a grant of 132.183 restricted stock units (RSUs) on 09/26/2025 under the company's 2022 Long-Term Incentive Plan. The filing shows the RSUs were issued at $0 in connection with accrued dividend equivalent rights tied to previously granted RSUs, and those units vest on the third anniversary of the original grant date. After this transaction the reporting person beneficially owns 124,686.639 shares. The report notes 14,454 shares held by the reporting person’s spouse are not included in that total.
Form 4 disclosure: Executive Vice President Jeffrey M. Farber of The Hanover Insurance Group (THG) reported an acquisition on 09/26/2025 of 48.815 shares of common stock in the form of restricted stock units (RSUs) at a $0 price. After the grant, he beneficially owns 45,991.495 shares. The filing states these RSUs were issued under the company’s 2022 Long-Term Incentive Plan as dividend equivalent accruals tied to earlier RSU awards and will vest on the third anniversary of the original grants.
This is an insider compensation-related grant rather than an open-market purchase or sale; the transaction was certified on 09/30/2025.
Richard W. Lavey, Executive Vice President and director of Hanover Insurance Group (THG), reported a non-derivative acquisition on 09/26/2025. The Form 4 shows 30.586 shares acquired at a price of $0 and reports 39,142.294 shares beneficially owned following the transaction. The filing explains these shares are restricted stock units (RSUs) issued under the company's 2022 Long-Term Incentive Plan as dividend equivalent rights tied to previously granted RSUs; these RSUs vest on the third anniversary of the original RSU grant date. The filing is signed via confirming statement by Lindsay L. Katz on 09/30/2025.
The reporting person, David John Lovely, Executive Vice President of The Hanover Insurance Group, Inc. (THG), received 11.375 shares of common stock on 09/26/2025 at no cost as a grant of restricted stock units (RSUs). These RSUs were issued under the company's 2022 Long-Term Incentive Plan as accruals for dividend equivalent rights tied to previously granted RSUs. After the grant, the reporting person beneficially owns 2,277.625 shares (reported as direct ownership). The granted RSUs vest on the third anniversary of the original underlying RSU grant date.
The filing shows that Willard T. Lee, Executive Vice President of Hanover Insurance Group (THG), was granted restricted stock units (RSUs) on 09/26/2025 under the company’s 2022 Long-Term Incentive Plan. The grant is described as dividend-equivalent RSUs tied to previously awarded RSUs; these new RSUs vest on the third anniversary of the original RSU grant date. The reported transaction lists 11.859 shares acquired at a price of $0, and the filing reports 5,479.704 shares beneficially owned following the transaction.